244 related articles for article (PubMed ID: 31763783)
1. Risk of malignancy in "atypia of undetermined significance" category of salivary gland fine-needle aspiration: A bi-institutional experience.
Alruwaii F; Hang JF; Zeng BR; Cramer HM; Lai CR; De la Sancha C; Wu HH
Diagn Cytopathol; 2020 Feb; 48(2):138-143. PubMed ID: 31763783
[TBL] [Abstract][Full Text] [Related]
2. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.
Maleki Z; Baloch Z; Lu R; Shafique K; Song SJ; Viswanathan K; Rao RA; Lefler H; Fatima A; Wiles A; Jo VY; Wang H; Fadda G; Powers CN; Ali SZ; Pantanowitz L; Siddiqui MT; Nayar R; Klijanienko J; Barkan GA; Krane JF; Rossi ED; Callegari F; Kholová I; Bongiovanni M; Faquin WC; Pusztaszeri MP
Cancer Cytopathol; 2019 May; 127(5):306-315. PubMed ID: 31050186
[TBL] [Abstract][Full Text] [Related]
3. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience.
Viswanathan K; Sung S; Scognamiglio T; Yang GCH; Siddiqui MT; Rao RA
Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690
[TBL] [Abstract][Full Text] [Related]
4. Application of the Milan System for Reporting Salivary Gland Cytopathology in pediatric patients: An international, multi-institutional study.
Maleki Z; Saoud C; Viswanathan K; Kilic I; Tommola E; Griffin DT; Heider A; Petrone G; Jo VY; Centeno BA; Saieg M; Mikou P; Fadda G; Ali SZ; Kholová I; Wojcik EM; Barkan GA; Eisele DW; Bellevicine C; Vigliar E; Wiles AB; Al-Ibraheemi A; Allison DB; Dixon GR; Chandra A; Walsh JM; Baloch ZW; Faquin WC; Krane JF; Rossi ED; Pantanowitz L; Troncone G; Callegari FM; Klijanienko J
Cancer Cytopathol; 2022 May; 130(5):370-380. PubMed ID: 35081269
[TBL] [Abstract][Full Text] [Related]
5. Application of the Milan System for Reporting Salivary Gland Cytopathology: A Retrospective 12-Year Bi-institutional Study.
Wu HH; Alruwaii F; Zeng BR; Cramer HM; Lai CR; Hang JF
Am J Clin Pathol; 2019 May; 151(6):613-621. PubMed ID: 30852595
[TBL] [Abstract][Full Text] [Related]
6. Application of the Milan System for Reporting Salivary Gland Cytopathology to cystic salivary gland lesions.
Maleki Z; Allison DB; Butcher M; Kawamoto S; Eisele DW; Pantanowitz L
Cancer Cytopathol; 2021 Mar; 129(3):214-225. PubMed ID: 33002347
[TBL] [Abstract][Full Text] [Related]
7. Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of uncertain malignant potential (SUMP): A 3-year institutional experience.
Cormier CM; Agarwal S
Cancer Cytopathol; 2022 Apr; 130(4):303-312. PubMed ID: 34875145
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification and clinical outcome in the atypia of undetermined significance category in the Milan System for Reporting Salivary Gland Cytopathology.
Wangsiricharoen S; Maleki Z
Cancer Cytopathol; 2021 Feb; 129(2):132-139. PubMed ID: 32936993
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland fine-needle aspiration cytology with the application of the Milan system for risk stratification and histological correlation: A retrospective 6-year study.
Rivera Rolon M; Schnadig VJ; Faiz S; Nawgiri R; Clement CG
Diagn Cytopathol; 2020 Nov; 48(11):1067-1074. PubMed ID: 32452653
[TBL] [Abstract][Full Text] [Related]
10. Retrospective implementation of the Milan system for reporting salivary gland cytopathology; a review of 5 years in a specialized cancer center.
Jaber OI; Shawash SI
Diagn Cytopathol; 2021 Feb; 49(2):187-194. PubMed ID: 33002325
[TBL] [Abstract][Full Text] [Related]
11. A retrospective comparison of salivary gland fine needle aspiration reporting with the Milan system for reporting salivary gland cytology.
Mullen D; Gibbons D
Cytopathology; 2020 May; 31(3):208-214. PubMed ID: 32061105
[TBL] [Abstract][Full Text] [Related]
12. The Milan system for reporting salivary gland cytopathology: Single center experience with cell blocks.
Behaeghe M; Vander Poorten V; Hermans R; Politis C; Weynand B; Hauben E
Diagn Cytopathol; 2020 Nov; 48(11):972-978. PubMed ID: 32506684
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study.
Chowsilpa S; An D; Lose H; Huang X; Nayar R; Maleki Z
Cancer Cytopathol; 2019 Jun; 127(6):377-389. PubMed ID: 31116514
[TBL] [Abstract][Full Text] [Related]
14. Application of the Milan System for Reporting Salivary Gland Cytopathology: A 10-Year Experience in a Single Japanese Institution.
Hirata Y; Higuchi K; Tamashiro K; Koja K; Yasutomi Y; Matsuzaki A; Yoshimi N
Acta Cytol; 2021; 65(2):123-131. PubMed ID: 33113539
[TBL] [Abstract][Full Text] [Related]
15. The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens.
Song SJ; Shafique K; Wong LQ; LiVolsi VA; Montone KT; Baloch Z
Cytopathology; 2019 Jan; 30(1):91-98. PubMed ID: 30303566
[TBL] [Abstract][Full Text] [Related]
16. Northern Italy in the American South: Assessing interobserver reliability within the Milan System for Reporting Salivary Gland Cytopathology.
Hollyfield JM; O'Connor SM; Maygarden SJ; Greene KG; Scanga LR; Tang S; Dodd LG; Wobker SE
Cancer Cytopathol; 2018 Jun; 126(6):390-396. PubMed ID: 29579353
[TBL] [Abstract][Full Text] [Related]
17. The Milan system for reporting salivary gland cytology: A retrospective analysis of 1384 cases in a tertiary Southeast Asian institution.
Lee JJL; Tan HM; Chua DYS; Chung JGK; Nga ME
Cancer Cytopathol; 2020 May; 128(5):348-358. PubMed ID: 32022995
[TBL] [Abstract][Full Text] [Related]
18. Application of the Milan System for Reporting Salivary Gland Cytopathology: Experience of an academic institution in a tertiary academic medical center.
Castrodad-Rodríguez CA; Lajara S; Khader SN; Colanta AB; Guerrero DR; El Hussein S; Hakima L
Cancer Cytopathol; 2021 Mar; 129(3):204-213. PubMed ID: 33030811
[TBL] [Abstract][Full Text] [Related]
19. Subtyping salivary gland neoplasm of uncertain malignant potential based on cell type demonstrates differential risk of malignancy.
Hang JF; Alruwaii F; Zeng BR; Lai CR; Wu HH
Cancer Cytopathol; 2018 Nov; 126(11):924-933. PubMed ID: 30335220
[TBL] [Abstract][Full Text] [Related]
20. Retrospective application of the Milan System for reporting salivary gland cytopathology: A Cancer Center experience.
Leite AA; Vargas PA; Dos Santos Silva AR; Galvis MM; de Sá RS; Lopes Pinto CA; Kowalski LP; Saieg M
Diagn Cytopathol; 2020 Sep; 48(9):821-826. PubMed ID: 32374949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
